glp 1 2024 GLP-1 Pipeline Update: November - Prime Therapeutics Researchers find GLP-1 medications safe
Description
Wegovy (semaglutide) EPAR
Specific criteria include a BMI of 35 kg/m or above (or lower in certain ethnic groups), problems associated with high weight, or if insulin would otherwise be initiated but presents significant occupational implications
January 30, 2026
Taking home leftovers is a practical strategy that also provides a ready-made meal for later
CORPORATE DEVELOPMENTS Kedaara Capital to Exit Universal NutriScience - INDIA - March 11 Kedaara Capital is preparing to sell Universal NutriScience for an expected 3,000 crore valuation, with Rothschild appointed to advise
